Corticosteroids Increase Atrial Fibrillation Risk in Patients With COVID-19
Researchers sought to examine whether patients with COVID-19 receiving steroids develop new-onset atrial fibrillation.
AHA 2021
Long-Term Beta-Blocker Use Reduces Recurrent ACS After Myocardial Infarction
Investigators performed a retrospective observational study to determine if long-term use of beta-blockers is associated with risk for recurrent ischemic events or all-cause mortality.
ICIs Linked With Higher Risk for Cancer Therapy-Related Cardiac Dysfunction
In a study presented at AHA 2021, researchers aimed to assess the link between cancer therapy-related cardiac dysfunction and immune checkpoint inhibitors.
DOACs and VKAs Similarly Efficacious for Black Patients vs General Population
In a landmark trial presented at AHA 2021, researchers aimed to understand the safety and efficacy of direct oral anticoagulants vs vitamin K antagonists in Black patients with non-valvular atrial fibrillation and venous thromboembolism.
Nardilysin Detection May Signal Early Onset Non-ST-Segment Elevation ACS
Research presented at AHA 2021 showed that a certain biomarker could potentially help with the early diagnosis of non-ST-segment elevation acute coronary syndrome.
Certain BP Treatments Less Effective in Patients With Diabetes
Investigators assessed the impact of diabetes mellitus on the efficacy of a low-dose, triple combination, polypill or standard care for the treatment of hypertension.
Genotype Testing Effectively Guides Post-PCI P2Y12 Inhibitor Therapy
Patients with ACS who underwent percutaneous coronary intervention benefited from a genotype-guided P2Y12 inhibitor antiplatelet strategy.
Cardiovascular Outcomes With SGLT2 Inhibitors in T2D Compared
A network meta-analysis was done to compare the effectiveness of SGLT2 inhibitors in participants with type 2 diabetes and cardiovascular risk factors.
Hypertensive Crisis Hospitalizations Higher in Non-White Men Using Cannabis
Researchers at AHA 2021 presented a study that examined rates of hypertensive crisis in young cannabis users vs nonusers of different race and sex.
High Leptin Increases Mortality Risk in Stable Coronary Heart Disease
Researchers at AHA 2021 presented a study that sought to determine whether high leptin affects the risk for mortality or morbidity in patients with stable CHD.
Ticagrelor Superior After PCI for Acute Coronary Syndrome
A nationwide registry-based study presented at AHA 2021 finds that ticagrelor is associated with a lower risk of bleeding after PCI for ACS.
No Difference in Antihypertensive Medication Dosing in Morning vs Evening
Researchers reported their findings on the effects of antihypertensive dosing in morning vs evening on patient prognosis at AHA 2021.
Empagliflozin Improves Cardiovascular Outcomes for Those With CVD
Among patients with type 2 diabetes, empagliflozin showed greater benefits in patients with CVD vs without.
TAT With Cilostazol + DAT May Increase Health Risks Compared With DAT Alone
Researchers aimed to study the effects of DAT alone or TAT for 1 month or 6 months in patients who previously underwent primary percutaneous coronary intervention.
Cardiovascular Disease Risk Increased in Young, Black US Adults
Researchers at AHA 2021 presented their findings from a study that compared CVD risk factors and in-hospital outcomes in young, Black US adults a decade apart.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in AHA 2021
Loading... 
Loading...